+86 13759939507
Echinacea Extract (Chicoric Acid & Echinacoside) | Expert in Immunomodulation & Respiratory Health Ingredients
-
Certificates
+ISO9001; HACCP; HALAL -
Product Specification
+4% chicoric acid + ≥2.5% echinacoside -
Factory Environment
+CGMP Factory
-
Product Advantages
+Batch Ready Stock; Raw Material guarantee; ＜50ppm（Compliant with USP/EP standards） -
Product Evaluation
+Testing Report; Meet EU Grade -
Product Deliveries
+DHL, Fedex, UPS, EMS, as request
What is Ashwagandha Extract?
|
Product Name: |
Echinacea Extract |
Latin Name: |
Echinacea purpurea |
|
Specification: |
4% chicoric acid + ≥2.5% echinacoside |
Appearance: |
Greenish Brown Color
|
|
Test Method: |
HPLC |
Brand: |
Risun |
Echinacea purpurea extract is a multifunctional medicinal ingredient extracted from the whole herb of Echinacea purpurea, the main active substances include cichoric acid, polysaccharides, polyphenols and caffeic acid derivatives. The extract has a variety of biological activities such as immunomodulatory, anti-inflammatory, antibacterial and antiviral, and a 2024 study showed that its chloroform extract exhibited immune recovery function in mouse experiments.
Echinacea purpurea Extract | Immune defense and inflammation Regulation system
Extraction technology
Full spectrum active retention process:
Low-temperature dynamic countercurrent extraction: Simultaneously retains Cichoric acid
Multi-stage membrane separation: Total polyphenol content ≥ 8% (ORAC value ≥ 15,000 μmol TE/g)
Balance of active ingredients: Scientific ratio of aerial parts and root extracts (3:1 for optimal synergy)
Quality benchmarks:
USP certified
EU EMA standard compliant
Microbiological testing (total aerobic bacteria <100 CFU/g)
Core active ingredient matrix
Characteristic efficacy components:
Cichoric acid ≥4% - main anti-inflammatory ingredient
Echinacoside ≥2.5% - neuroprotective effect
Multi-dimensional mechanism of action:
Immune cell activation:
Enhances neutrophil phagocytic activity (+55%)
Promotes IL-6 secretion (ELISA detection +3 times)
Antiviral defense:
Inhibits influenza virus neuraminidase (IC50=12.3μM)
Blocking coronavirus 3CL protease (molecular docking verification)
Tissue repair:
Accelerates fibroblast migration (wound healing time shortened by 40%)
Stimulates collagen deposition (hydroxyproline content +28%)
Clinical evidence of efficacyies
Respiratory defense
Cold duration: Shortened by 1.8 days (Meta-analysis, n=2,500+)
Relapse rate: Decreased by 35% (child population follow-up study)
Immune regulation
Immune regulation
Vaccination: Antibody titer increased 2.1 times (influenza vaccine adjuvant trial)
Postoperative infection: Incidence decreased 62% (surgical patient control)
Skin health
Atopic dermatitis: SCORAD score improved 43% (12 weeks of topical use)
Propionibacterium acnes: Inhibition zone diameter reached 15mm (agar diffusion method)
Neuroprotection
Anxiety score: GAD-7 scale decreased 38% (8 weeks of intervention)
Cognitive function: Digital symbol test improved 21%
Technical parameters
|
Item |
Specification |
|
Appearance |
Brown fine powder |
|
Active ingredients |
Chicoric acid ≥4% + echinacoside ≥2.5% |
|
Solubility |
Water-alcohol soluble (30% ethanol system is recommended) |
|
Recommended dosage |
Prevention: 300 mg/day Acute phase: 600 mg/day (divided into 3 times) |
|
Stability |
24 months (avoid light, RH <60%) |
Application scenarios and formula solutions
Respiratory health
Quick-acting cold granules: 400mg extract + zinc (shortening the course of the disease formula)
Seasonal defense gummies: Low-dose formula for children (100 mg/tablet)
Immune enhancement
Vaccine booster drops: Sublingual mucosal absorption (use 7 days before and after vaccination)
Postoperative recovery capsules: Sustained release technology (continuous immune support)
Skin care
Wound repair gel: 2% Echinacea + Centella asiatica (synergistic enhancement)
Anti-acne serum: 1% nano inclusions (targeted hair follicles)
Nervous health
Anxiety relief tablets: Compounded with ashwagandha (3:2 ratio)
Brain fog improvement powder: Instant type (caffeine alternative)
Usage specifications and contraindications
Recommended solutions
Preventive care: 300 mg/day (stop for 1 week after 8 consecutive weeks)
Acute symptoms: 800 mg (divided) on the first day, 600 mg/day thereafter
Topical preparations: 1-3% addition (1-2 times a day)
recautions
⛔ Precautions
⛔ Precautions
Autoimmune diseases: Use with caution during active phase (doctor's guidance required)
History of allergy to Asteraceae: Contraindicated (risk of cross-allergy)
Transplant patients: Contraindicated (may interfere with immunosuppressants)
FAQ
Q: Is Echinacea effective against the new coronavirus?
A: In vitro studies have shown that its alkylamides can inhibit the activity of 3CL protease (preprint study), but it has not yet been clinically approved and is recommended for routine immune support.
Q: Is it safe for children to use?
A: We provide a low-dose formula designed for children (removing some alkylamides), which can be safely used by children over 4 years old (clinical study n=120).
Q: Can it be used in combination with elderberry?
A: A 1:1 combination is recommended (elderberry inhibits viral replication + echinacea enhances immunity), which synergistically reduces the incidence of colds by 72%.
